People: Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

20 Sep 2019
Change (% chg)

$-0.02 (-0.11%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Preston, Heather 

Dr. Heather Preston, M.D., is Independent Director of the Company. Dr. Preston has served as a member of our Board of Directors since December 2007. Since July 2018, Dr. Preston has served as managing partner at Pivotal BioVenture Partners and as a Senior Advisor of TPG Biotech, a biotechnology venture capital firm. Dr. Preston was previously a Partner and Managing Director at TPG Biotech, from 2005 to July 2018. Prior to joining TPG Biotech, Dr. Preston served for two years as a medical device and biotechnology venture capital investor at J.P. Morgan Partners, LLC, a private equity firm. Prior to that, she was an Entrepreneur-in-Residence at New Enterprise Associates, a venture capital firm, and was a leader of the pharmaceutical and medical products consulting practice at McKinsey & Co in New York. Dr. Preston currently serves on the board of directors of Entasis Therapeutics Holdings, Inc., Oxford BioMedica plc, Otonomy, Inc. and numerous private companies. Dr. Preston holds an M.D. from the University of Oxford and a B.S. in Biochemistry from the University of London.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 48,394
Fiscal Year Total, USD 48,394

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Azelby


Carlos Campoy


Erin Lavelle


James Bucher


Randal Hassler


Nadia Dac

As Of  31 Dec 2018